drugset / Trial / NCT00305110
Safety of Hydromorphone in Adult Patients Presenting to the Emergency Department With Acute Severe Pain
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the safety and speed of onset of 2mg intravenous hydromorphone (Dilaudid) in patients weighing at least 150 lbs presenting to the emergency department with acute severe pain
Timeline
- Start
- 2006-01
- Primary completion
- 2006-10
- Completion
- 2006-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hydromorphone | Other / unclassified | 2 mg | Intravenous |
Indications
No indication recorded.